Adjuvant Gemcitabine plus Docetaxel Followed by Doxorubicin Versus Observation for Uterus-Limited, High-Grade Leiomyosarcoma: A Phase Iii Gog Study.
AuthID
P-00V-TB8
P-00V-TB8
© 2025 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service